Thank you, Mr. Chair.
This is an area of active work not only with the research community, as Dr. Strong just said, and with the Public Health Agency in working with their partners to better understand the prevalence and presentation of long COVID, but also with the provinces and territories in terms of supports.
We had a discussion on this just last week at the council of deputy ministers of health in terms of specific centres or clinics that some provinces are establishing; work to develop clinical guidance in terms of assessing treatment modalities linked with research programs; and work that is more from a health policy perspective in terms of assessing the potential future impacts—both health and, more broadly, social and economic—which will be supported by the research that Dr. Strong spoke about through the Canadian Institutes of Health Research.